Myotonia congenita

Myotonia congenita
ICD-10	G71.1
ICD-9	359.2
OMIM	160800
DiseasesDB	8736
MeSH	D009224

WikiDoc Resources for Myotonia congenita
Articles
Most recent articles on Myotonia congenita Most cited articles on Myotonia congenita Review articles on Myotonia congenita Articles on Myotonia congenita in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Myotonia congenita Images of Myotonia congenita Photos of Myotonia congenita Podcasts & MP3s on Myotonia congenita Videos on Myotonia congenita
Evidence Based Medicine
Cochrane Collaboration on Myotonia congenita Bandolier on Myotonia congenita TRIP on Myotonia congenita
Clinical Trials
Ongoing Trials on Myotonia congenita at Clinical Trials.gov Trial results on Myotonia congenita Clinical Trials on Myotonia congenita at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Myotonia congenita NICE Guidance on Myotonia congenita NHS PRODIGY Guidance FDA on Myotonia congenita CDC on Myotonia congenita
Books
Books on Myotonia congenita
News
Myotonia congenita in the news Be alerted to news on Myotonia congenita News trends on Myotonia congenita
Commentary
Blogs on Myotonia congenita
Definitions
Definitions of Myotonia congenita
Patient Resources / Community
Patient resources on Myotonia congenita Discussion groups on Myotonia congenita Patient Handouts on Myotonia congenita Directions to Hospitals Treating Myotonia congenita Risk calculators and risk factors for Myotonia congenita
Healthcare Provider Resources
Symptoms of Myotonia congenita Causes & Risk Factors for Myotonia congenita Diagnostic studies for Myotonia congenita Treatment of Myotonia congenita
Continuing Medical Education (CME)
CME Programs on Myotonia congenita
International
Myotonia congenita en Espanol Myotonia congenita en Francais
Business
Myotonia congenita in the Marketplace Patents on Myotonia congenita
Experimental / Informatics
List of terms related to Myotonia congenita

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Myotonia congenita is a genetic, neuromuscular disorder characterized by the slow relaxation of the muscles. Symptoms may include muscle stiffness and hypertrophy (enlargement). The disorder is caused by a genetic mutation involving the chloride channel of the muscles. The muscle stiffness, which particularly occurs in the leg muscles, may be enhanced by cold and inactivity, and is often relieved by exercise.

Types

Historically two forms of myotonia congenita have been classified. The less severe form has been termed Thomsen myotonia congenita and is inherited in a dominant fashion; the more severe form has been termed Becker myotonia congenita and is inherited in a recessive fashion. More recently, as the individual mutations that give rise to this condition have been identified, these classifications are less widely used. The onset of the myotonia congenita is typically before the age of 20; most cases of myotonia congenita are nonprogressive and relatively nonlimiting.

It is important to note that involuntary twitches in skeletal muscle may not be caused by myotonia congenita as a far more common cause is fasciculation arising from benign fasciculation syndrome.

Goats of the "fainting goat" breed all suffer from this condition.

Genetics

Mutations in the CLCN1 gene cause myotonia congenita. The CLCN1 gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. For the body to move normally, skeletal muscles must tense (contract) and relax in a coordinated way. Muscle contraction and relaxation are controlled by the flow of ions into and out of muscle cells. Specifically, the protein produced from the CLCN1 gene forms a channel that controls the flow of negatively charged chloride ions into these cells. The main function of this channel is to stabilize the cells' electrical charge, which prevents muscles from contracting abnormally.

Mutations in the CLCN1 gene alter the usual structure or function of chloride channels. The altered channels cannot properly regulate ion flow, reducing the movement of chloride ions into skeletal muscle cells. This disruption in chloride ion flow triggers prolonged muscle contractions, which are the hallmark of myotonia.

The two forms of myotonia congenita have different patterns of inheritance. Thomsen disease is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition.

Becker disease is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive disorder each carry one copy of the altered gene, but do not show signs and symptoms of the disorder.

Because several CLCN1 mutations can cause either Becker disease or Thomsen disease, doctors usually rely on characteristic signs and symptoms to distinguish the two forms of myotonia congenita.

Treatment

Some cases of myotonia congenita do not require treatment. If necessary, however, symptoms of the disorder may be relieved with quinine, phenytoin, and mexiletine and other anticonvulsant drugs. Physical therapy and other rehabilitative measures may also be used to help muscle function. Genetic counseling is available.

References

• Template:NINDS
• National Library of Medicine. Myotonia congenita